Foundry Partners LLC Buys 8,561 Shares of Select Medical Holdings Co. (NYSE:SEM)

Foundry Partners LLC boosted its position in Select Medical Holdings Co. (NYSE:SEM) by 3.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 245,860 shares of the health services provider’s stock after buying an additional 8,561 shares during the period. Foundry Partners LLC owned approximately 0.19% of Select Medical worth $8,573,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Hexagon Capital Partners LLC increased its stake in Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 645 shares in the last quarter. Transcendent Capital Group LLC bought a new stake in Select Medical during the 2nd quarter worth approximately $35,000. Canada Pension Plan Investment Board purchased a new stake in shares of Select Medical in the second quarter worth approximately $39,000. DekaBank Deutsche Girozentrale purchased a new position in shares of Select Medical during the second quarter valued at approximately $60,000. Finally, GAMMA Investing LLC lifted its stake in Select Medical by 52.8% during the 2nd quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock valued at $70,000 after acquiring an additional 685 shares in the last quarter. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Stock Performance

Shares of SEM stock opened at $38.09 on Thursday. The stock has a market capitalization of $4.93 billion, a P/E ratio of 17.80, a PEG ratio of 1.66 and a beta of 1.42. Select Medical Holdings Co. has a 12 month low of $22.26 and a 12 month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm’s 50 day moving average is $34.93 and its 200 day moving average is $34.92.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.46 EPS. On average, sell-side analysts anticipate that Select Medical Holdings Co. will post 2.16 earnings per share for the current year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be given a $0.125 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.31%. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on SEM shares. Bank of America initiated coverage on shares of Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. Benchmark restated a “buy” rating and set a $48.00 price target on shares of Select Medical in a research report on Friday, November 1st. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.